| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/08/1998 | EP0833916A1 Decorin binding protein compositions and methods of use |
| 04/08/1998 | EP0833914A1 Human chemokine beta-11 and human chemokine alpha-1 |
| 04/08/1998 | EP0833913A1 Antigen non-specific glycosylation inhibiting factor derivatives |
| 04/08/1998 | EP0833912A1 Novel tgf-beta like cytokine |
| 04/08/1998 | EP0833911A1 Cdr-grafted anti-tissue factor antibodies and methods of use thereof |
| 04/08/1998 | EP0833909A1 Protein with differentiation-inducing activity for friend's erythroleukemia cell lines |
| 04/08/1998 | EP0833907A1 Transcriptional regulation of genes encoding vascular endothelial growth factor receptors |
| 04/08/1998 | EP0833906A2 Novel ctla4/cd28 ligands and uses therefor |
| 04/08/1998 | EP0833904A1 Fibroblast growth factor-14 |
| 04/08/1998 | EP0833902A2 Oligonucleotides specific for hepatitis c virus |
| 04/08/1998 | EP0833897A2 Prothrombin derivatives |
| 04/08/1998 | EP0833893A1 Isolation of mammalian hematopoietic stem cells |
| 04/08/1998 | EP0833892A1 Human hepatoma-derived growth factor-2 |
| 04/08/1998 | EP0833848A1 Factor ix binding peptides, derived from factor viii and their use as inhibitors of blood coagulation |
| 04/08/1998 | EP0833845A1 Compounds with growth hormone releasing properties |
| 04/08/1998 | EP0833844A1 SINGLE CHAIN ANALOGS OF THE TGF-$g(b) SUPERFAMILY (MORPHONS) |
| 04/08/1998 | EP0833843A2 Depigmenting activity of agouti signal protein and peptides thereof |
| 04/08/1998 | EP0833842A1 Novel peptides for use in treatment of t-cell mediated cartilage destruction in autoimmune diseases |
| 04/08/1998 | EP0833841A1 New family of linear antimicrobial peptides from hagfish intestine |
| 04/08/1998 | EP0833840A1 Hypoxia inducible factor-1 and method of use |
| 04/08/1998 | EP0833839A1 Peptidyl heterocycles useful in the treatment of thrombin related disorders |
| 04/08/1998 | EP0833835A1 Obesity protein intermediates and their preparation and use |
| 04/08/1998 | EP0833834A1 Dna sequence and encoded mammary-specific breast cancer protein |
| 04/08/1998 | EP0833670A2 Rotavirus enterotoxin nsp4 and methods of using same |
| 04/08/1998 | EP0833668A1 Inhibition of hepatitis b replication |
| 04/08/1998 | EP0833666A2 Cytomodulating conjugates of members of specific binding pairs |
| 04/08/1998 | EP0833665A1 Compositions containing nucleic acids and ligands for therapeutic treatment |
| 04/08/1998 | EP0833663A1 Carbohydrate-mediated coupling of peptides to immunoglobulins |
| 04/08/1998 | EP0833659A1 Therapeutic fragments of von willebrand factor |
| 04/08/1998 | EP0833658A1 Inhibin compositions and methods of enhancing production performance |
| 04/08/1998 | EP0833657A1 A method for the control of antibiotic-resistant gram positive bacteria and treatment of infection |
| 04/08/1998 | EP0833656A2 Pharmaceutical compositions comprising restrictin p/activin a and use thereof as antagonist of il-6 and/or il-11 |
| 04/08/1998 | EP0833655A1 Pharmaceutical preparation with cyclosporin a |
| 04/08/1998 | EP0833654A1 Peptides and compounds that bind to the il-1 receptor |
| 04/08/1998 | EP0833653A1 Serum immunoregulatory polypeptides and uses therefor |
| 04/08/1998 | EP0833652A1 Novel kappa receptor selective opioid peptides |
| 04/08/1998 | EP0833651A1 ANALGESIC USE OF N-L-$g(a)-ASPARTYL-L-PHENYLALANINE 1-METHYL ESTER |
| 04/08/1998 | EP0833650A1 P-selectin ligands and related molecules and methods |
| 04/08/1998 | EP0833649A1 Methods of preventing or treating allergies |
| 04/08/1998 | EP0833648A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES |
| 04/08/1998 | EP0833647A1 Method for treating tumors with a toxin |
| 04/08/1998 | EP0833646A1 Multi-tyrosinated somatostatin analogs |
| 04/08/1998 | EP0833644A1 Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders |
| 04/08/1998 | EP0833636A1 Method for inhibiting neoplastic disease in mammals |
| 04/08/1998 | EP0833629A2 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 04/08/1998 | EP0833623A1 Method for treating multiple sclerosis |
| 04/08/1998 | EP0833620A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells |
| 04/08/1998 | EP0833614A1 System and method for producing drug-loaded microparticles |
| 04/08/1998 | EP0833573A1 Active principle carriers containing non-ionic surfactants, and uses thereof, particularly in food, cosmetics and pharmaceuticals |
| 04/08/1998 | EP0630405B1 Novel V28 seven transmembrane receptor |
| 04/08/1998 | EP0558681B1 Treatment for tissue ulceration |
| 04/08/1998 | EP0558630B1 Retroviral protease inhibitors |
| 04/08/1998 | EP0512042B1 Glp-1 analogs useful for diabetes treatment |
| 04/08/1998 | EP0439508B1 Polyethylene glycolcol (peg)-protein adducts and process for their fractionation |
| 04/08/1998 | CN1178554A chemically modified interperon |
| 04/08/1998 | CN1178553A Recombinant DNA prepared by intergrating DNA that codes for myosin heavy-chtain SMI isoform protein into vector DNA, and arteriosclerosis remedy both containing the recombinant DNA |
| 04/08/1998 | CN1178552A New difined enzyme mixture for obtaining cells and treating wounds |
| 04/08/1998 | CN1178471A Treatment of diabetic neuropathy |
| 04/08/1998 | CN1178470A Collagen-based method and formulations for treatment of immune system-mediated diseases |
| 04/08/1998 | CN1178469A Treatment of cerebral ischemia and cerebral damage with neuroprotective agent |
| 04/08/1998 | CN1178460A Use of compositions comprising stabilized biologically effective compounds |
| 04/08/1998 | CN1178106A Cyclosphorin-containing soft capsule preparation |
| 04/07/1998 | US5736574 Comprising a hydrolipid and at least one glyceryl monoalkyl ether |
| 04/07/1998 | US5736565 Therapeutic compounds suitable for the treatment of diseases connected with glutathione deficiency, process for their preparation, and pharmaceutical compositions containing same |
| 04/07/1998 | US5736559 Cardiovascular disorders; respiratory system disorders |
| 04/07/1998 | US5736535 1-pyrimidinylacetamide compounds which are inhibitors of human leukocyte elastase |
| 04/07/1998 | US5736521 Administering amino acid compound |
| 04/07/1998 | US5736520 Peptidase inhibitors |
| 04/07/1998 | US5736519 Enhances reconstitution of cells of hematopoietic and immune systems following radiation or chemotherapy induced suppression |
| 04/07/1998 | US5736518 Hypotensive agents; analgesics; immuno-modulating; antiinflammatory agents; resistant to enzyme hydrolysis;drugs for oral administering |
| 04/07/1998 | US5736517 Administering to treat colon, prostate or breast cancer |
| 04/07/1998 | US5736516 Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein protein |
| 04/07/1998 | US5736515 Use of growth hormone for increasement of concentration of GH, IGF-I and IGFBP-3 in cerebrospinal fluid |
| 04/07/1998 | US5736511 Methods for treatment using acid-labile subunit (ALS) of insulin-like growth factor binding protein complex |
| 04/07/1998 | US5736510 Antibiotics 10381v, w, x,y, z1, z2, pre-b and t |
| 04/07/1998 | US5736508 Administering streptolysin an antiscarring agent, wound healing agent and for aging resistance |
| 04/07/1998 | US5736507 Peptide of human cartilage glycoprotein 39, which stimulates autoreactive t-cells found in blood of rheumatoid arthritis patients |
| 04/07/1998 | US5736506 Mixture with polysaccharide |
| 04/07/1998 | US5736400 Method for modifying, diagnosing and screening for IGF-I sensitive cell barriers |
| 04/07/1998 | US5736396 Lineage-directed induction of human mesenchymal stem cell differentiation |
| 04/07/1998 | US5736394 Cellular uptake of modified peptides |
| 04/07/1998 | US5736391 HIV gp41 mutants |
| 04/07/1998 | US5736390 BCRF1 proteins as inhibitors of interferon-γ |
| 04/07/1998 | US5736389 Treatment of colorectal cancer |
| 04/07/1998 | US5736387 Envelope fusion vectors for use in gene delivery |
| 04/07/1998 | US5736381 An isolated and purified polynucleotide sequence encoding a polypeptide containing specific amino acid sequence |
| 04/07/1998 | US5736378 Molecular cloning and characterization of the feline immunodeficiency virus isolate PPR |
| 04/07/1998 | US5736368 Self assembled defective non-self propagating lentiviral particles |
| 04/07/1998 | US5736364 Factor viia inhibitors |
| 04/07/1998 | US5736363 Insulin-like growth factor; polypeptide |
| 04/07/1998 | US5736362 An isolated nucleic acid comprising nucleotide sequence encoding amino acid sequence 25-276 of a rye grass pollen protein |
| 04/07/1998 | US5736347 Nucleic acids of Rochalimaea henselae and methods and compositions for diagnosing Rochalimaea henselae and Rochalimaea quintana infection |
| 04/07/1998 | US5736340 Secreted Mac-2-binding glycoprotein |
| 04/07/1998 | US5736339 Method utilizing purified GP IIb-IIIa to detect the presence of platelet aggregation inhibitors |
| 04/07/1998 | US5736338 Method of diagnosing Neoplastic disease by detecting increased expression of human MDM2 protein |
| 04/07/1998 | US5736337 Inhibiting protein interactions |
| 04/07/1998 | US5736336 Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility |
| 04/07/1998 | US5736321 Peptides effective for diagnosis and detection of hepatitis C infection |
| 04/07/1998 | US5736294 Genetic engineering |
| 04/07/1998 | US5736154 Multilayered, intra-lesional, interferon delivery which doesn't pass into blood stream; for treatuble carcinomas |